APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Preventable Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Preventable Vaccines Market Analysis and Forecast 2026-2032

Report ID 174028400227 December 2025218 pages

Choose your research edition.

Industry ResearchPreventable Vaccines Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Preventable Vaccines Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Preventable Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Preventable Vaccines Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal Preventable Vaccines Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Preventable Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Preventable Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Preventable Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Preventable Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Preventable Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Preventable Vaccines include Bausch Health, Bavarian Nordic, Bharat Biotech, Crucell, Dynavax, Janssen Pharmaceuticals, LG Life Sciences, Lupin and Mitsubishi Tanabe Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Preventable Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Preventable Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Preventable Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Preventable Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Preventable Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Preventable Vaccines sales, projected growth trends, production technology, application and end-user industry.

Preventable Vaccines Segment by Company

Bausch Health

Bavarian Nordic

Bharat Biotech

Crucell

Dynavax

Janssen Pharmaceuticals

LG Life Sciences

Lupin

Mitsubishi Tanabe Pharma

Panacea Biotec

Protein Sciences

S K Chemicals

Serum Institute of India

Sinovac Biotech

Takeda Pharmaceutical

AstraZeneca

Baxter

GlaxoSmithKline

Pfizer

Roche

Merck

Novartis

Sanofi

Shenzhen Kangtai Biological Products

Abbott

Preventable Vaccines Segment by Type

Adult Preventable Vaccines

Pediatric Preventable Vaccines

Preventable Vaccines Segment by Application

Bacterial Diseases

Virus Diseases

Preventable Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Preventable Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Preventable Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Preventable Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Preventable Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Preventable Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Preventable Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Preventable Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Adult Preventable Vaccines Major Manufacturers Table 3. Pediatric Preventable Vaccines Major Manufacturers Table 4. Global Preventable Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Bacterial Diseases Major Manufacturers Table 6. Virus Diseases Major Manufacturers Table 7. Preventable Vaccines Industry Trends Table 8. Preventable Vaccines Industry Drivers Table 9. Preventable Vaccines Industry Opportunities and Challenges Table 10. Preventable Vaccines Industry Restraints Table 11. Global Preventable Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Preventable Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Preventable Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Preventable Vaccines Revenue Market Share by Region (2021-2026) Table 15. Global Preventable Vaccines Revenue Market Share by Region (2027-2032) Table 16. Global Preventable Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 17. Global Preventable Vaccines Sales by Region (2021-2026) & (W Units) Table 18. Global Preventable Vaccines Sales by Region (2027-2032) & (W Units) Table 19. Global Preventable Vaccines Sales Market Share by Region (2021-2026) Table 20. Global Preventable Vaccines Sales Market Share by Region (2027-2032) Table 21. Global Preventable Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Preventable Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Preventable Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Preventable Vaccines Sales Market Share by Manufacturers (2021-2026) Table 25. Global Preventable Vaccines Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Preventable Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Preventable Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Preventable Vaccines Manufacturers, Product Type & Application Table 29. Global Preventable Vaccines Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Preventable Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Preventable Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Preventable Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Preventable Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Preventable Vaccines Revenue Market Share by Type (2021-2026) Table 36. Global Preventable Vaccines Revenue Market Share by Type (2027-2032) Table 37. Global Preventable Vaccines Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 38. Global Preventable Vaccines Sales by Type (2021-2026) & (W Units) Table 39. Global Preventable Vaccines Sales by Type (2027-2032) & (W Units) Table 40. Global Preventable Vaccines Sales Market Share by Type (2021-2026) Table 41. Global Preventable Vaccines Sales Market Share by Type (2027-2032) Table 42. Global Preventable Vaccines Price by Type (2021-2026) & (US$/Unit) Table 43. Global Preventable Vaccines Price by Type (2027-2032) & (US$/Unit) Table 44. Global Preventable Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Preventable Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Preventable Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Preventable Vaccines Revenue Market Share by Application (2021-2026) Table 48. Global Preventable Vaccines Revenue Market Share by Application (2027-2032) Table 49. Global Preventable Vaccines Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 50. Global Preventable Vaccines Sales by Application (2021-2026) & (W Units) Table 51. Global Preventable Vaccines Sales by Application (2027-2032) & (W Units) Table 52. Global Preventable Vaccines Sales Market Share by Application (2021-2026) Table 53. Global Preventable Vaccines Sales Market Share by Application (2027-2032) Table 54. Global Preventable Vaccines Price by Application (2021-2026) & (US$/Unit) Table 55. Global Preventable Vaccines Price by Application (2027-2032) & (US$/Unit) Table 56. Bausch Health Company Information Table 57. Bausch Health Business Overview Table 58. Bausch Health Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Bausch Health Preventable Vaccines Product Portfolio Table 60. Bausch Health Recent Development Table 61. Bavarian Nordic Company Information Table 62. Bavarian Nordic Business Overview Table 63. Bavarian Nordic Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Bavarian Nordic Preventable Vaccines Product Portfolio Table 65. Bavarian Nordic Recent Development Table 66. Bharat Biotech Company Information Table 67. Bharat Biotech Business Overview Table 68. Bharat Biotech Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Bharat Biotech Preventable Vaccines Product Portfolio Table 70. Bharat Biotech Recent Development Table 71. Crucell Company Information Table 72. Crucell Business Overview Table 73. Crucell Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Crucell Preventable Vaccines Product Portfolio Table 75. Crucell Recent Development Table 76. Dynavax Company Information Table 77. Dynavax Business Overview Table 78. Dynavax Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Dynavax Preventable Vaccines Product Portfolio Table 80. Dynavax Recent Development Table 81. Janssen Pharmaceuticals Company Information Table 82. Janssen Pharmaceuticals Business Overview Table 83. Janssen Pharmaceuticals Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Janssen Pharmaceuticals Preventable Vaccines Product Portfolio Table 85. Janssen Pharmaceuticals Recent Development Table 86. LG Life Sciences Company Information Table 87. LG Life Sciences Business Overview Table 88. LG Life Sciences Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. LG Life Sciences Preventable Vaccines Product Portfolio Table 90. LG Life Sciences Recent Development Table 91. Lupin Company Information Table 92. Lupin Business Overview Table 93. Lupin Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Lupin Preventable Vaccines Product Portfolio Table 95. Lupin Recent Development Table 96. Mitsubishi Tanabe Pharma Company Information Table 97. Mitsubishi Tanabe Pharma Business Overview Table 98. Mitsubishi Tanabe Pharma Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Mitsubishi Tanabe Pharma Preventable Vaccines Product Portfolio Table 100. Mitsubishi Tanabe Pharma Recent Development Table 101. Panacea Biotec Company Information Table 102. Panacea Biotec Business Overview Table 103. Panacea Biotec Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Panacea Biotec Preventable Vaccines Product Portfolio Table 105. Panacea Biotec Recent Development Table 106. Protein Sciences Company Information Table 107. Protein Sciences Business Overview Table 108. Protein Sciences Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Protein Sciences Preventable Vaccines Product Portfolio Table 110. Protein Sciences Recent Development Table 111. S K Chemicals Company Information Table 112. S K Chemicals Business Overview Table 113. S K Chemicals Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. S K Chemicals Preventable Vaccines Product Portfolio Table 115. S K Chemicals Recent Development Table 116. Serum Institute of India Company Information Table 117. Serum Institute of India Business Overview Table 118. Serum Institute of India Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Serum Institute of India Preventable Vaccines Product Portfolio Table 120. Serum Institute of India Recent Development Table 121. Sinovac Biotech Company Information Table 122. Sinovac Biotech Business Overview Table 123. Sinovac Biotech Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Sinovac Biotech Preventable Vaccines Product Portfolio Table 125. Sinovac Biotech Recent Development Table 126. Takeda Pharmaceutical Company Information Table 127. Takeda Pharmaceutical Business Overview Table 128. Takeda Pharmaceutical Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Takeda Pharmaceutical Preventable Vaccines Product Portfolio Table 130. Takeda Pharmaceutical Recent Development Table 131. AstraZeneca Company Information Table 132. AstraZeneca Business Overview Table 133. AstraZeneca Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. AstraZeneca Preventable Vaccines Product Portfolio Table 135. AstraZeneca Recent Development Table 136. Baxter Company Information Table 137. Baxter Business Overview Table 138. Baxter Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Baxter Preventable Vaccines Product Portfolio Table 140. Baxter Recent Development Table 141. GlaxoSmithKline Company Information Table 142. GlaxoSmithKline Business Overview Table 143. GlaxoSmithKline Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. GlaxoSmithKline Preventable Vaccines Product Portfolio Table 145. GlaxoSmithKline Recent Development Table 146. Pfizer Company Information Table 147. Pfizer Business Overview Table 148. Pfizer Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Pfizer Preventable Vaccines Product Portfolio Table 150. Pfizer Recent Development Table 151. Roche Company Information Table 152. Roche Business Overview Table 153. Roche Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Roche Preventable Vaccines Product Portfolio Table 155. Roche Recent Development Table 156. Merck Company Information Table 157. Merck Business Overview Table 158. Merck Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Merck Preventable Vaccines Product Portfolio Table 160. Merck Recent Development Table 161. Novartis Company Information Table 162. Novartis Business Overview Table 163. Novartis Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Novartis Preventable Vaccines Product Portfolio Table 165. Novartis Recent Development Table 166. Sanofi Company Information Table 167. Sanofi Business Overview Table 168. Sanofi Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 169. Sanofi Preventable Vaccines Product Portfolio Table 170. Sanofi Recent Development Table 171. Shenzhen Kangtai Biological Products Company Information Table 172. Shenzhen Kangtai Biological Products Business Overview Table 173. Shenzhen Kangtai Biological Products Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 174. Shenzhen Kangtai Biological Products Preventable Vaccines Product Portfolio Table 175. Shenzhen Kangtai Biological Products Recent Development Table 176. Abbott Company Information Table 177. Abbott Business Overview Table 178. Abbott Preventable Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 179. Abbott Preventable Vaccines Product Portfolio Table 180. Abbott Recent Development Table 181. North America Preventable Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 182. North America Preventable Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 183. North America Preventable Vaccines Sales by Type (2021-2026) & (W Units) Table 184. North America Preventable Vaccines Sales by Type (2027-2032) & (W Units) Table 185. North America Preventable Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 186. North America Preventable Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 187. North America Preventable Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 188. North America Preventable Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 189. North America Preventable Vaccines Sales by Application (2021-2026) & (W Units) Table 190. North America Preventable Vaccines Sales by Application (2027-2032) & (W Units) Table 191. North America Preventable Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 192. North America Preventable Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 193. North America Preventable Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 194. North America Preventable Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 195. North America Preventable Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 196. North America Preventable Vaccines Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 197. North America Preventable Vaccines Sales by Country (2021-2026) & (W Units) Table 198. North America Preventable Vaccines Sales by Country (2027-2032) & (W Units) Table 199. North America Preventable Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 200. North America Preventable Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 201. United States Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 202. Canada Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 203. Mexico Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 204. Europe Preventable Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 205. Europe Preventable Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 206. Europe Preventable Vaccines Sales by Type (2021-2026) & (W Units) Table 207. Europe Preventable Vaccines Sales by Type (2027-2032) & (W Units) Table 208. Europe Preventable Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 209. Europe Preventable Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 210. Europe Preventable Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 211. Europe Preventable Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 212. Europe Preventable Vaccines Sales by Application (2021-2026) & (W Units) Table 213. Europe Preventable Vaccines Sales by Application (2027-2032) & (W Units) Table 214. Europe Preventable Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 215. Europe Preventable Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 216. Europe Preventable Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 217. Europe Preventable Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 218. Europe Preventable Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 219. Europe Preventable Vaccines Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 220. Europe Preventable Vaccines Sales by Country (2021-2026) & (W Units) Table 221. Europe Preventable Vaccines Sales by Country (2027-2032) & (W Units) Table 222. Europe Preventable Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 223. Europe Preventable Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 224. Germany Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 225. France Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 226. U.K. Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 227. Italy Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 228. Russia Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 229. Spain Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 230. Netherlands Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 231. Switzerland Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 232. Sweden Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 233. Poland Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 234. China Preventable Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 235. China Preventable Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 236. China Preventable Vaccines Sales by Type (2021-2026) & (W Units) Table 237. China Preventable Vaccines Sales by Type (2027-2032) & (W Units) Table 238. China Preventable Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 239. China Preventable Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 240. China Preventable Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 241. China Preventable Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 242. China Preventable Vaccines Sales by Application (2021-2026) & (W Units) Table 243. China Preventable Vaccines Sales by Application (2027-2032) & (W Units) Table 244. China Preventable Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 245. China Preventable Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 246. Asia Preventable Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 247. Asia Preventable Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 248. Asia Preventable Vaccines Sales by Type (2021-2026) & (W Units) Table 249. Asia Preventable Vaccines Sales by Type (2027-2032) & (W Units) Table 250. Asia Preventable Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 251. Asia Preventable Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 252. Asia Preventable Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 253. Asia Preventable Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 254. Asia Preventable Vaccines Sales by Application (2021-2026) & (W Units) Table 255. Asia Preventable Vaccines Sales by Application (2027-2032) & (W Units) Table 256. Asia Preventable Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 257. Asia Preventable Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 258. Asia Preventable Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 259. Asia Preventable Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 260. Asia Preventable Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 261. Asia Preventable Vaccines Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 262. Asia Preventable Vaccines Sales by Country (2021-2026) & (W Units) Table 263. Asia Preventable Vaccines Sales by Country (2027-2032) & (W Units) Table 264. Asia Preventable Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 265. Asia Preventable Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 266. Japan Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 267. South Korea Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 268. India Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 269. Australia Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 270. Taiwan Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 271. Southeast Asia Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 272. SAMEA Preventable Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 273. SAMEA Preventable Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 274. SAMEA Preventable Vaccines Sales by Type (2021-2026) & (W Units) Table 275. SAMEA Preventable Vaccines Sales by Type (2027-2032) & (W Units) Table 276. SAMEA Preventable Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 277. SAMEA Preventable Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 278. SAMEA Preventable Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 279. SAMEA Preventable Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 280. SAMEA Preventable Vaccines Sales by Application (2021-2026) & (W Units) Table 281. SAMEA Preventable Vaccines Sales by Application (2027-2032) & (W Units) Table 282. SAMEA Preventable Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 283. SAMEA Preventable Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 284. SAMEA Preventable Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 285. SAMEA Preventable Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 286. SAMEA Preventable Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 287. SAMEA Preventable Vaccines Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 288. SAMEA Preventable Vaccines Sales by Country (2021-2026) & (W Units) Table 289. SAMEA Preventable Vaccines Sales by Country (2027-2032) & (W Units) Table 290. SAMEA Preventable Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 291. SAMEA Preventable Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 292. Brazil Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 293. Argentina Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 294. Chile Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 295. Colombia Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 296. Peru Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 297. Saudi Arabia Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 298. Israel Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 299. UAE Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 300. Turkey Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 301. Iran Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 302. Egypt Preventable Vaccines Revenue (2021-2032) & (US$ Million) Table 303. Key Raw Materials Table 304. Raw Materials Key Suppliers Table 305. Preventable Vaccines Distributors List Table 306. Preventable Vaccines Customers List Table 307. Research Programs/Design for This Report Table 308. Authors List of This Report Table 309. Secondary Sources Table 310. Primary Sources List of Figures Figure 1. Preventable Vaccines Image Figure 2. Global Preventable Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Preventable Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Adult Preventable Vaccines Image Figure 5. Pediatric Preventable Vaccines Image Figure 6. Global Preventable Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Preventable Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 8. Bacterial Diseases Image Figure 9. Virus Diseases Image Figure 10. Global Preventable Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Preventable Vaccines Revenue (2021-2032) & (US$ Million) Figure 12. Global Preventable Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Preventable Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Preventable Vaccines Revenue Market Share by Region (2021-2032) Figure 15. Global Preventable Vaccines Sales (2021-2032) & (W Units) Figure 16. Global Preventable Vaccines Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 17. Global Preventable Vaccines Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Preventable Vaccines Sales YoY (2021-2032) & (W Units) Figure 19. Europe Preventable Vaccines Sales YoY (2021-2032) & (W Units) Figure 20. China Preventable Vaccines Sales YoY (2021-2032) & (W Units) Figure 21. Asia (Excluding China) Preventable Vaccines Sales YoY (2021-2032) & (W Units) Figure 22. South America, Middle East and Africa Preventable Vaccines Sales YoY (2021-2032) & (W Units) Figure 23. Global Preventable Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Preventable Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Preventable Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Preventable Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Preventable Vaccines Revenue Market Share by Type (2021-2032) Figure 29. Global Preventable Vaccines Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 30. Global Preventable Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Preventable Vaccines Sales Market Share by Type (2021-2032) Figure 32. Global Preventable Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Preventable Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Preventable Vaccines Revenue Market Share by Application (2021-2032) Figure 35. Global Preventable Vaccines Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 36. Global Preventable Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Preventable Vaccines Sales Market Share by Application (2021-2032) Figure 38. North America Preventable Vaccines Revenue Share by Type (2021-2032) Figure 39. North America Preventable Vaccines Sales Share by Type (2021-2032) Figure 40. North America Preventable Vaccines Revenue Share by Application (2021-2032) Figure 41. North America Preventable Vaccines Sales Share by Application (2021-2032) Figure 42. North America Preventable Vaccines Revenue Share by Country (2021-2032) Figure 43. North America Preventable Vaccines Sales Share by Country (2021-2032) Figure 44. Europe Preventable Vaccines Revenue Share by Type (2021-2032) Figure 45. Europe Preventable Vaccines Sales Share by Type (2021-2032) Figure 46. Europe Preventable Vaccines Revenue Share by Application (2021-2032) Figure 47. Europe Preventable Vaccines Sales Share by Application (2021-2032) Figure 48. Europe Preventable Vaccines Revenue Share by Country (2021-2032) Figure 49. Europe Preventable Vaccines Sales Share by Country (2021-2032) Figure 50. China Preventable Vaccines Revenue Share by Type (2021-2032) Figure 51. China Preventable Vaccines Sales Share by Type (2021-2032) Figure 52. China Preventable Vaccines Revenue Share by Application (2021-2032) Figure 53. China Preventable Vaccines Sales Share by Application (2021-2032) Figure 54. Asia Preventable Vaccines Revenue Share by Type (2021-2032) Figure 55. Asia Preventable Vaccines Sales Share by Type (2021-2032) Figure 56. Asia Preventable Vaccines Revenue Share by Application (2021-2032) Figure 57. Asia Preventable Vaccines Sales Share by Application (2021-2032) Figure 58. Asia Preventable Vaccines Revenue Share by Country (2021-2032) Figure 59. Asia Preventable Vaccines Sales Share by Country (2021-2032) Figure 60. SAMEA Preventable Vaccines Revenue Share by Type (2021-2032) Figure 61. SAMEA Preventable Vaccines Sales Share by Type (2021-2032) Figure 62. SAMEA Preventable Vaccines Revenue Share by Application (2021-2032) Figure 63. SAMEA Preventable Vaccines Sales Share by Application (2021-2032) Figure 64. SAMEA Preventable Vaccines Revenue Share by Country (2021-2032) Figure 65. SAMEA Preventable Vaccines Sales Share by Country (2021-2032) Figure 66. Preventable Vaccines Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Preventable Vaccines Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Adult Preventable Vaccines
  • Pediatric Preventable Vaccines
Applications
  • Bacterial Diseases
  • Virus Diseases
Companies covered
  • Bausch Health
  • Bavarian Nordic
  • Bharat Biotech
  • Crucell
  • Dynavax
  • Janssen Pharmaceuticals
  • LG Life Sciences
  • Lupin
  • Mitsubishi Tanabe Pharma
  • Panacea Biotec
  • Protein Sciences
  • S K Chemicals
  • Serum Institute of India
  • Sinovac Biotech
  • Takeda Pharmaceutical
  • AstraZeneca
  • Baxter
  • GlaxoSmithKline
  • Pfizer
  • Roche
  • Merck
  • Novartis
  • Sanofi
  • Shenzhen Kangtai Biological Products
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Preventable Vaccines Market by Type
  3. 1.2.1 Global Preventable Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Adult Preventable Vaccines
  5. 1.2.3 Pediatric Preventable Vaccines
  6. 1.3 Preventable Vaccines Market by Application
  7. 1.3.1 Global Preventable Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Bacterial Diseases
  9. 1.3.3 Virus Diseases
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Preventable Vaccines Market Dynamics
  1. 2.1 Preventable Vaccines Industry Trends
  2. 2.2 Preventable Vaccines Industry Drivers
  3. 2.3 Preventable Vaccines Industry Opportunities and Challenges
  4. 2.4 Preventable Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Preventable Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Preventable Vaccines Revenue by Region
  3. 3.2.1 Global Preventable Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Preventable Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global Preventable Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global Preventable Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Preventable Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Preventable Vaccines Sales by Region
  9. 3.4.1 Global Preventable Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Preventable Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global Preventable Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global Preventable Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Preventable Vaccines Revenue by Manufacturers
  2. 4.1.1 Global Preventable Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Preventable Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Preventable Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Preventable Vaccines Sales by Manufacturers
  6. 4.2.1 Global Preventable Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Preventable Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Preventable Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Preventable Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Preventable Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Preventable Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Preventable Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global Preventable Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Preventable Vaccines Market CR5 and HHI
  16. 4.8.2 2025 Preventable Vaccines Tier 1, Tier 2, and Tier 3
5 Preventable Vaccines Market by Type
  1. 5.1 Global Preventable Vaccines Revenue by Type
  2. 5.1.1 Global Preventable Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Preventable Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Preventable Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Preventable Vaccines Sales by Type
  6. 5.2.1 Global Preventable Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Preventable Vaccines Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Preventable Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Preventable Vaccines Price by Type
6 Preventable Vaccines Market by Application
  1. 6.1 Global Preventable Vaccines Revenue by Application
  2. 6.1.1 Global Preventable Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Preventable Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Preventable Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Preventable Vaccines Sales by Application
  6. 6.2.1 Global Preventable Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Preventable Vaccines Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Preventable Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Preventable Vaccines Price by Application
7 Company Profiles
  1. 7.1 Bausch Health
  2. 7.1.1 Bausch Health Company Information
  3. 7.1.2 Bausch Health Business Overview
  4. 7.1.3 Bausch Health Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bausch Health Preventable Vaccines Product Portfolio
  6. 7.1.5 Bausch Health Recent Developments
  7. 7.2 Bavarian Nordic
  8. 7.2.1 Bavarian Nordic Company Information
  9. 7.2.2 Bavarian Nordic Business Overview
  10. 7.2.3 Bavarian Nordic Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bavarian Nordic Preventable Vaccines Product Portfolio
  12. 7.2.5 Bavarian Nordic Recent Developments
  13. 7.3 Bharat Biotech
  14. 7.3.1 Bharat Biotech Company Information
  15. 7.3.2 Bharat Biotech Business Overview
  16. 7.3.3 Bharat Biotech Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Bharat Biotech Preventable Vaccines Product Portfolio
  18. 7.3.5 Bharat Biotech Recent Developments
  19. 7.4 Crucell
  20. 7.4.1 Crucell Company Information
  21. 7.4.2 Crucell Business Overview
  22. 7.4.3 Crucell Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Crucell Preventable Vaccines Product Portfolio
  24. 7.4.5 Crucell Recent Developments
  25. 7.5 Dynavax
  26. 7.5.1 Dynavax Company Information
  27. 7.5.2 Dynavax Business Overview
  28. 7.5.3 Dynavax Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Dynavax Preventable Vaccines Product Portfolio
  30. 7.5.5 Dynavax Recent Developments
  31. 7.6 Janssen Pharmaceuticals
  32. 7.6.1 Janssen Pharmaceuticals Company Information
  33. 7.6.2 Janssen Pharmaceuticals Business Overview
  34. 7.6.3 Janssen Pharmaceuticals Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Janssen Pharmaceuticals Preventable Vaccines Product Portfolio
  36. 7.6.5 Janssen Pharmaceuticals Recent Developments
  37. 7.7 LG Life Sciences
  38. 7.7.1 LG Life Sciences Company Information
  39. 7.7.2 LG Life Sciences Business Overview
  40. 7.7.3 LG Life Sciences Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 LG Life Sciences Preventable Vaccines Product Portfolio
  42. 7.7.5 LG Life Sciences Recent Developments
  43. 7.8 Lupin
  44. 7.8.1 Lupin Company Information
  45. 7.8.2 Lupin Business Overview
  46. 7.8.3 Lupin Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Lupin Preventable Vaccines Product Portfolio
  48. 7.8.5 Lupin Recent Developments
  49. 7.9 Mitsubishi Tanabe Pharma
  50. 7.9.1 Mitsubishi Tanabe Pharma Company Information
  51. 7.9.2 Mitsubishi Tanabe Pharma Business Overview
  52. 7.9.3 Mitsubishi Tanabe Pharma Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Mitsubishi Tanabe Pharma Preventable Vaccines Product Portfolio
  54. 7.9.5 Mitsubishi Tanabe Pharma Recent Developments
  55. 7.10 Panacea Biotec
  56. 7.10.1 Panacea Biotec Company Information
  57. 7.10.2 Panacea Biotec Business Overview
  58. 7.10.3 Panacea Biotec Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Panacea Biotec Preventable Vaccines Product Portfolio
  60. 7.10.5 Panacea Biotec Recent Developments
  61. 7.11 Protein Sciences
  62. 7.11.1 Protein Sciences Company Information
  63. 7.11.2 Protein Sciences Business Overview
  64. 7.11.3 Protein Sciences Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Protein Sciences Preventable Vaccines Product Portfolio
  66. 7.11.5 Protein Sciences Recent Developments
  67. 7.12 S K Chemicals
  68. 7.12.1 S K Chemicals Company Information
  69. 7.12.2 S K Chemicals Business Overview
  70. 7.12.3 S K Chemicals Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 S K Chemicals Preventable Vaccines Product Portfolio
  72. 7.12.5 S K Chemicals Recent Developments
  73. 7.13 Serum Institute of India
  74. 7.13.1 Serum Institute of India Company Information
  75. 7.13.2 Serum Institute of India Business Overview
  76. 7.13.3 Serum Institute of India Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Serum Institute of India Preventable Vaccines Product Portfolio
  78. 7.13.5 Serum Institute of India Recent Developments
  79. 7.14 Sinovac Biotech
  80. 7.14.1 Sinovac Biotech Company Information
  81. 7.14.2 Sinovac Biotech Business Overview
  82. 7.14.3 Sinovac Biotech Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Sinovac Biotech Preventable Vaccines Product Portfolio
  84. 7.14.5 Sinovac Biotech Recent Developments
  85. 7.15 Takeda Pharmaceutical
  86. 7.15.1 Takeda Pharmaceutical Company Information
  87. 7.15.2 Takeda Pharmaceutical Business Overview
  88. 7.15.3 Takeda Pharmaceutical Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Takeda Pharmaceutical Preventable Vaccines Product Portfolio
  90. 7.15.5 Takeda Pharmaceutical Recent Developments
  91. 7.16 AstraZeneca
  92. 7.16.1 AstraZeneca Company Information
  93. 7.16.2 AstraZeneca Business Overview
  94. 7.16.3 AstraZeneca Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 AstraZeneca Preventable Vaccines Product Portfolio
  96. 7.16.5 AstraZeneca Recent Developments
  97. 7.17 Baxter
  98. 7.17.1 Baxter Company Information
  99. 7.17.2 Baxter Business Overview
  100. 7.17.3 Baxter Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Baxter Preventable Vaccines Product Portfolio
  102. 7.17.5 Baxter Recent Developments
  103. 7.18 GlaxoSmithKline
  104. 7.18.1 GlaxoSmithKline Company Information
  105. 7.18.2 GlaxoSmithKline Business Overview
  106. 7.18.3 GlaxoSmithKline Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 GlaxoSmithKline Preventable Vaccines Product Portfolio
  108. 7.18.5 GlaxoSmithKline Recent Developments
  109. 7.19 Pfizer
  110. 7.19.1 Pfizer Company Information
  111. 7.19.2 Pfizer Business Overview
  112. 7.19.3 Pfizer Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Pfizer Preventable Vaccines Product Portfolio
  114. 7.19.5 Pfizer Recent Developments
  115. 7.20 Roche
  116. 7.20.1 Roche Company Information
  117. 7.20.2 Roche Business Overview
  118. 7.20.3 Roche Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Roche Preventable Vaccines Product Portfolio
  120. 7.20.5 Roche Recent Developments
  121. 7.21 Merck
  122. 7.21.1 Merck Company Information
  123. 7.21.2 Merck Business Overview
  124. 7.21.3 Merck Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Merck Preventable Vaccines Product Portfolio
  126. 7.21.5 Merck Recent Developments
  127. 7.22 Novartis
  128. 7.22.1 Novartis Company Information
  129. 7.22.2 Novartis Business Overview
  130. 7.22.3 Novartis Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Novartis Preventable Vaccines Product Portfolio
  132. 7.22.5 Novartis Recent Developments
  133. 7.23 Sanofi
  134. 7.23.1 Sanofi Company Information
  135. 7.23.2 Sanofi Business Overview
  136. 7.23.3 Sanofi Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Sanofi Preventable Vaccines Product Portfolio
  138. 7.23.5 Sanofi Recent Developments
  139. 7.24 Shenzhen Kangtai Biological Products
  140. 7.24.1 Shenzhen Kangtai Biological Products Company Information
  141. 7.24.2 Shenzhen Kangtai Biological Products Business Overview
  142. 7.24.3 Shenzhen Kangtai Biological Products Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  143. 7.24.4 Shenzhen Kangtai Biological Products Preventable Vaccines Product Portfolio
  144. 7.24.5 Shenzhen Kangtai Biological Products Recent Developments
  145. 7.25 Abbott
  146. 7.25.1 Abbott Company Information
  147. 7.25.2 Abbott Business Overview
  148. 7.25.3 Abbott Preventable Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  149. 7.25.4 Abbott Preventable Vaccines Product Portfolio
  150. 7.25.5 Abbott Recent Developments
8 North America
  1. 8.1 North America Preventable Vaccines Market Size by Type
  2. 8.1.1 North America Preventable Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America Preventable Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America Preventable Vaccines Price by Type (2021-2032)
  5. 8.2 North America Preventable Vaccines Market Size by Application
  6. 8.2.1 North America Preventable Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America Preventable Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America Preventable Vaccines Price by Application (2021-2032)
  9. 8.3 North America Preventable Vaccines Market Size by Country
  10. 8.3.1 North America Preventable Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Preventable Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Preventable Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Preventable Vaccines Market Size by Type
  2. 9.1.1 Europe Preventable Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe Preventable Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe Preventable Vaccines Price by Type (2021-2032)
  5. 9.2 Europe Preventable Vaccines Market Size by Application
  6. 9.2.1 Europe Preventable Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe Preventable Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe Preventable Vaccines Price by Application (2021-2032)
  9. 9.3 Europe Preventable Vaccines Market Size by Country
  10. 9.3.1 Europe Preventable Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Preventable Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Preventable Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Preventable Vaccines Market Size by Type
  2. 10.1.1 China Preventable Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China Preventable Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China Preventable Vaccines Price by Type (2021-2032)
  5. 10.2 China Preventable Vaccines Market Size by Application
  6. 10.2.1 China Preventable Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China Preventable Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China Preventable Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Preventable Vaccines Market Size by Type
  2. 11.1.1 Asia Preventable Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia Preventable Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia Preventable Vaccines Price by Type (2021-2032)
  5. 11.2 Asia Preventable Vaccines Market Size by Application
  6. 11.2.1 Asia Preventable Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia Preventable Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia Preventable Vaccines Price by Application (2021-2032)
  9. 11.3 Asia Preventable Vaccines Market Size by Country
  10. 11.3.1 Asia Preventable Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Preventable Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Preventable Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Preventable Vaccines Market Size by Type
  2. 12.1.1 SAMEA Preventable Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Preventable Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Preventable Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA Preventable Vaccines Market Size by Application
  6. 12.2.1 SAMEA Preventable Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Preventable Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Preventable Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA Preventable Vaccines Market Size by Country
  10. 12.3.1 SAMEA Preventable Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Preventable Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Preventable Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Preventable Vaccines Value Chain Analysis
  2. 13.1.1 Preventable Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Preventable Vaccines Production Mode & Process
  6. 13.2 Preventable Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Preventable Vaccines Distributors
  9. 13.2.3 Preventable Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst